Similar Papers

Paper Title
Journal
Date
Author
A5.11 alarmins S100A8/S100A9 stimulate osteophyte formation in experimental osteoarthritis and predict osteophyte progression in early human osteoarthritis
R F P Schelbergen ... F P J G Lafeber
Annals of the Rheumatic Diseases | VOL. 73
R F P Schelbergen, et. al.R F P Schelbergen ... F P J G Lafeber
31 Jan 2014
OP0146 Alarmins S100a8/S100a9 Aggravate Osteophyte Formation in Experimental Osteoarthritis and PREDICT Osteophyte Progression in Early Human Osteoarthritis in the Dutch CHECK Cohort
R Schelbergen ... W.B Van Den Berg
Annals of the Rheumatic Diseases | VOL. 73
R Schelbergen, et. al.R Schelbergen ... W.B Van Den Berg
01 Jun 2014
Prophylactic treatment with S100A9 inhibitor paquinimod reduces pathology in experimental collagenase-induced osteoarthritis
R F Schelbergen ... J Roth
Annals of the Rheumatic Diseases | VOL. 74
R F Schelbergen, et. al.R F Schelbergen ... J Roth
12 May 2015
AB0073 The s100a9 inhibitor paquinimod (abr-215757) ameliorates experimental osteoarthritis with high synovial involvement
R Schelbergen ... W Van Den Berg
Annals of the Rheumatic Diseases | VOL. 72
R Schelbergen, et. al.R Schelbergen ... W Van Den Berg
01 Jun 2013
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
Greetings from the Editor - 2025.
Josef Smolen
Annals of the rheumatic diseases | VOL. 84
Josef SmolenJosef Smolen
01 Jan 2025
Bridging the gap: tackling the challenge of limited progressors in clinical trials aimed at slowing the transition from early preradiographic to established osteoarthritis.
Francis Berenbaum ... Marc Buyse
Annals of the rheumatic diseases | VOL. 84
Francis Berenbaum, et. al.Francis Berenbaum ... Marc Buyse
01 Jan 2025
Systematic literature review and meta-analysis informing the EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer.
Eden Sebbag ... Jacques-Eric Gottenberg
Annals of the rheumatic diseases | VOL. -
Eden Sebbag, et. al.Eden Sebbag ... Jacques-Eric Gottenberg
20 Dec 2024
2024 EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer
Eden Sebbag ... Jacques-Eric Gottenberg
Annals of the Rheumatic Diseases | VOL. -
Eden Sebbag, et. al.Eden Sebbag ... Jacques-Eric Gottenberg
19 Dec 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.